Thorium-227-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - April 21, 2021 Category: Cancer & Oncology Authors: Ola Lind én Andrew T. Bates David Cunningham Cecilia Hindorf Erik Larsson Adriaan Cleton Joerg Pinkert Funan Huang Friedhelm Bladt Hartwig Hennekes Liv-Ingrid Oedegaardstuen Isrid Sturm Christopher McNamara Source Type: research